Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: JACC Heart Fail. 2014 Apr;2(2):113–122. doi: 10.1016/j.jchf.2013.11.004

Table 4.

Characteristics of HFpEF patients without or with wtTTR amyloid

wtTTR Absent wtTTR
Present
p value
n 88 18
Male 43% 43% 0.98
Age at heart failure event, years 72±13 86±7 <0.001
Age at death, years 74±12 89±8 <0.001
Hypertension 78% 78% 0.95
Diabetes mellitus 44% 33% 0.39
Coronary artery disease 62% 61% 0.94
Ejection fraction at heart failure event, % 59±9 59±9 1.0
Autopsy Findings
Heart weight at autopsy, g 557±164 470±140 0.04
Percent expected heart weight 182±53 152±28 0.02
Gross left ventricular hypertrophy 68% 67% 0.90
Gross right ventricular hypertrophy 50% 33% 0.20
Gross infarct (old) 44% 39% 0.67
Gross fibrosis 19% 11% 0.41
Gross infarct (new) 11% 11% 0.98
Left ventricular dilatation 39% 39% 0.98
Right ventricular dilatation 49% 44% 0.73
Atrial dilatation 55% 56% 0.94
Microscopic fibrosis 53% 72% 0.14
Microscopic hypertrophy 27% 44% 0.15
Microscopic infarct 14% 33% 0.04
Coronary disease score 11±4 11±4 0.66
% Fibrosis (WFDM) 12±7 17±14 0.02
ECG findings closest to Death
n 66 12
Low QRS voltage (limb) 5% 8% 0.58
Low QRS voltage (precordial) 3% 8% 0.38